In this review article, we will discuss the available evidence of programmed cell death protein-1(PD-1)/programmed death ligand-1(PD-L1) blockade in pancreatic cancer and the potential roles of PD-L1 expression and microsatellite instability (MSI) as prognostic/predictive biomarkers. This evidence concerns the gene PDCD1 and pancreatic neoplasm.